News Focus
News Focus
icon url

PioneerPhoenix73

09/18/24 9:43 AM

#41591 RE: boston745 #41589

Counterargument 1: The occurrence of chronic wounds is a major global health issue.

Rebuttal: While chronic wounds are a significant problem, it's important to note that they are often associated with underlying health conditions such as diabetes and circulatory disorders. Addressing these underlying issues is crucial for effective wound healing, and the role of bacteria and fungi may be overstated.
Counterargument 2: Bacteria and Fungi are a major issue for wound care leading to chronic wounds.

Rebuttal: While bacteria and fungi can contribute to chronic wound infections, other factors such as inadequate blood flow, pressure, and poor nutrition are often more significant. The focus on microbial control may be diverting attention from these underlying causes.
Counterargument 3: These exact problems are seen in the catheter industry.

Rebuttal: While catheter-related infections are a concern, it's important to acknowledge that preventive measures such as proper insertion techniques and antiseptic care can significantly reduce the risk of microbial contamination. The emphasis on microbial control may be overshadowing the importance of these preventive strategies.
Counterargument 4: Silicon Nitride is a promising material for medical applications.

Rebuttal: While silicon nitride has shown promise in certain medical applications, it's important to consider the potential limitations and challenges. For example, the long-term biocompatibility of silicon nitride in various tissues and environments needs to be further evaluated. Additionally, the manufacturing and processing of silicon nitride can be complex and expensive, which may limit its widespread adoption.
Conclusion

While the potential benefits of silicon nitride in medical applications are promising, it's crucial to maintain a balanced perspective and consider the limitations and challenges associated with its use. Overemphasizing the role of microbial control in chronic wound healing and catheter infections may divert attention from other important factors, such as underlying health conditions and preventive measures.
icon url

boston745

09/18/24 12:50 PM

#41593 RE: boston745 #41589

Those problems present an enormous opportunity for Sintx and its partner(s) in the wound care/catherter markets. Imbuing wound care materials with Si3N4 will kill most bacteria and at least the most prevalent fungi like Candida. Coating catheters should do the same thing. However these things will take time to get to market with more testing and FDA submissions required. Thus its past-time for Sintx partner(s) in these two markets to step up, especially if WWIII is forthcoming.
If war is coming, along with another Pandemic, then its also past-time for PPE/protective apparel to get moving. If im correct about Solventum and Cardinal Health, then these two need to STEP-UP!

Global Catheter market = $55bn
Wound Care market = $22.25bn
Personal Protective Equipment market = $79.53 billion

Bill Gates says the world is facing two options: A ‘major war’ or another pandemic in less than 30 years

He cited “a lot of unrest” in the world at the moment, which could spark “a major war.”

But even if that conflict is avoided, “then yes, there will be another pandemic, most likely in the next 25 years,” Gates told CNBC Make It


There will definitely be another pandemic regardless if war occurs. Pandemics are connected to Solar Extrema. Thats why Monkeypox has been growing around Solar Max and the worst of Covid occurred around Solar Min.

Its unfortunate that war and pandemics would be good for Sintx but it also another reason why Zimmer Biomet would want the IP. Not only for diversification purposes but also because pandemics and war will hurt its business as was seen during COVID pandemic.


https://i.imgur.com/GUgo3Bb.png

Quote Source:
https://fortune.com/2024/09/10/bill-gates-fears-major-war-global-pandemic/

More on Solar Extrema and pandemics can be found here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175031022